Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Mineralo-organic particles inhibit influenza A virus infection by targeting viral hemagglutinin activity.

Autor: Chiang HJ; Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan.; Graduate Institute of Biomedical Science, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan., Peng HH; Center for Molecular & Clinical Immunology, Chang Gung University, Taoyuan, 33302, Taiwan.; Division of Chinese Medicine Obstetrics & Gynecology, Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, 33305, Taiwan.; Chang Gung Immunology Consortium, Chang Gung Memorial Hospital at Linkou, Taoyuan, 33305, Taiwan., Weng KF; Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan.; Department of Microbiology & Immunology, Stanford University SOM, Stanford, CA 94305, USA., Hsiung KC; Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan., Liang CY; Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan.; Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA., Kuo SL; Division of Chinese Medicine Obstetrics & Gynecology, Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, 33305, Taiwan.; School of Traditional Chinese Medicine, Chang Gung University, Taoyuan, 33302, Taiwan.; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan., Ojcius DM; Center for Molecular & Clinical Immunology, Chang Gung University, Taoyuan, 33302, Taiwan.; Chang Gung Immunology Consortium, Chang Gung Memorial Hospital at Linkou, Taoyuan, 33305, Taiwan.; Department of Biomedical Sciences, University of the Pacific, Arthur Dugoni School of Dentistry, San Francisco, CA 94103, USA., Young JD; Chang Gung Biotechnology Corporation, Taipei, 10508, Taiwan., Shih SR; Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan.; Department of Laboratory Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan.; Department of Medical Biotechnology & Laboratory Science, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan.; Research Center for Chinese Herbal Medicine, Research Center for Food & Cosmetic Safety, Graduate Institute of Health Industry Technology, College of Human Ecology, Chang Gung University of Science & Technology, Taoyuan, 33303, Taiwan.

Publikováno v: Nanomedicine (London, England) [Nanomedicine (Lond)] 2024; Vol. 19 (28), pp. 2375-2390. Date of Electronic Publication: 2024 Sep 25.

Loquacious modulates flaviviral RNA replication in mosquito cells.

Autor: Shivaprasad S; Department of Microbiology & Immunology, Stanford University SOM, Stanford, California, United Sates of America., Weng KF; Department of Microbiology & Immunology, Stanford University SOM, Stanford, California, United Sates of America., Ooi YS; Department of Microbiology & Immunology, Stanford University SOM, Stanford, California, United Sates of America., Belk J; Stanford ChEM-H, Stanford, California, United States of America., Carette JE; Department of Microbiology & Immunology, Stanford University SOM, Stanford, California, United Sates of America., Flynn R; Stanford ChEM-H, Stanford, California, United States of America., Sarnow P; Department of Microbiology & Immunology, Stanford University SOM, Stanford, California, United Sates of America.

Publikováno v: PLoS pathogens [PLoS Pathog] 2022 Apr 28; Vol. 18 (4), pp. e1010163. Date of Electronic Publication: 2022 Apr 28 (Print Publication: 2022).

Enterovirus pathogenesis requires the host methyltransferase SETD3.

Autor: Diep J; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA., Ooi YS; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA., Wilkinson AW; Department of Biology, Stanford University, Stanford, CA, USA., Peters CE; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA., Foy E; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA., Johnson JR; Department of Cellular Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA.; The J. David Gladstone Institutes, San Francisco, CA, USA., Zengel J; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA., Ding S; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, USA.; Palo Alto Veterans Institute of Research, VA Palo Alto Health Care System, Palo Alto, CA, USA., Weng KF; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA., Laufman O; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA., Jang G; Department of Cellular Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA.; The J. David Gladstone Institutes, San Francisco, CA, USA., Xu J; Department of Cellular Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA.; The J. David Gladstone Institutes, San Francisco, CA, USA., Young T; Department of Cellular Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Verschueren E; Department of Cellular Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Kobluk KJ; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA., Elias JE; Chan Zuckerberg Biohub, Mass Spectrometry Platform, Stanford, CA, USA., Sarnow P; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA., Greenberg HB; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, USA.; Palo Alto Veterans Institute of Research, VA Palo Alto Health Care System, Palo Alto, CA, USA., Hüttenhain R; Department of Cellular Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA.; The J. David Gladstone Institutes, San Francisco, CA, USA., Nagamine CM; Department of Comparative Medicine, Stanford University School of Medicine, Stanford, CA, USA., Andino R; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA. raul.andino@ucsf.edu., Krogan NJ; Department of Cellular Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA. nevan.krogan@gladstone.ucsf.edu.; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA, USA. nevan.krogan@gladstone.ucsf.edu.; The J. David Gladstone Institutes, San Francisco, CA, USA. nevan.krogan@gladstone.ucsf.edu., Gozani O; Department of Biology, Stanford University, Stanford, CA, USA. ogozani@stanford.edu., Carette JE; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA. carette@stanford.edu.

Publikováno v: Nature microbiology [Nat Microbiol] 2019 Dec; Vol. 4 (12), pp. 2523-2537. Date of Electronic Publication: 2019 Sep 16.

Pretreatment with a heat-killed probiotic modulates monocyte chemoattractant protein-1 and reduces the pathogenicity of influenza and enterovirus 71 infections.

Autor: Chen MF; Research Center for Emerging Viral Infections, Chang Gung University, Tao-Yuan, Taiwan, ROC., Weng KF; Research Center for Emerging Viral Infections, Chang Gung University, Tao-Yuan, Taiwan, ROC., Huang SY; Research Center for Emerging Viral Infections, Chang Gung University, Tao-Yuan, Taiwan, ROC.; Graduate Institute of Biomedical Sciences, Chang Gung University, Tao-Yuan, Taiwan, ROC., Liu YC; Research Center for Emerging Viral Infections, Chang Gung University, Tao-Yuan, Taiwan, ROC., Tseng SN; Research Center for Emerging Viral Infections, Chang Gung University, Tao-Yuan, Taiwan, ROC., Ojcius DM; Center for Molecular and Clinical Immunology, Chang Gung University, Tao-Yuan, Taiwan, ROC.; Department of Biomedical Sciences, University of the Pacific, Arthur Dugoni School of Dentistry, San Francisco, California, USA., Shih SR; Research Center for Emerging Viral Infections, Chang Gung University, Tao-Yuan, Taiwan, ROC.; Graduate Institute of Biomedical Sciences, Chang Gung University, Tao-Yuan, Taiwan, ROC.; Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Tao-Yuan, Taiwan, ROC.; Clinical Virology Laboratory, Department of Clinical Pathology, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan, ROC.

Publikováno v: Mucosal immunology [Mucosal Immunol] 2017 Jan; Vol. 10 (1), pp. 215-227. Date of Electronic Publication: 2016 Apr 13.